Accretion Pharmaceuticals launched its IPO on May 14, aiming to raise Rs 29.75 crore through a fresh issue of shares, with the IPO closing on May 16. The Gujarat-based company, which manufactures a range of healthcare products, plans to use the funds for capital expenditure, debt repayment, and working capital.
Banks, power finance and infrastructure to lead next leg of market rally: Pankaj Pandey
India’s banking sector is poised for a rally, fueled by robust credit growth, easing deposit pressures, and stable asset quality, according to ICICI Securities’ Pankaj